The Drug Enforcement Administration’s chief administrative law judge has stayed the marijuana rescheduling proceeding while ...
In this article, counsel Neil Willner examines how the Office of Cannabis Management has recently entered six pending New ...
National cannabis and psychedelics law firm providing services to marijuana, hemp, and psychedelics businesses, ancillary companies, investors, and governmental bodies ...
Vicente LLP partner Jason Tarasek joins a forum on healthcare, cannabis and Indigenous wellness at the 5th Annual Indigenous Biz Con on October 12, 2026 in Milwaukee, Wisconsin. The Drug Enforcement ...
The 2026 National Legal Education Conference, hosted by the National Association for Legal Support Professionals (NALS), takes place October 5–7 in Jacksonville, Florida at Mayo Clinic and features ...
While many novel food ingredients face straightforward FDA compliance questions, kratom, kava, blue lotus, kanna and similar emerging CPG products carry an added layer of risk considering the ...
In a sweeping blow to legal consumable hemp industries across the nation, Congress passed a new federal definition of “hemp” on November 12, 2025, which was signed into law by President Donald Trump ...
This is the first in a weekly series tracking the DEA’s marijuana rescheduling hearing as it unfolds. Check back each week for the latest testimony and analysis. Four days into the DEA’s marijuana ...
Denver—Today, the U.S. Department of Justice (DOJ) issued a Final Order (“the Order”) immediately placing both FDA-approved marijuana products and state-regulated medical marijuana products in ...
The Controlled Substances Act of 1970 (the “CSA”) divides drugs into five schedules based on potential for abuse and medical value. Marijuana moving from Schedule I (no accepted medical use, high ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results